20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Fulgent Genetics Inc (FLGT) operates in the DIAGNOSTICS & RESEARCH industry and is headquartered in El Monte, United States with about 1,315 employees. Its market capitalization is roughly $533 million. In the fiscal year ended 2025-12-31, FLGT reported $323M in revenue and ($61M) in net income.
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
Interactive charts & full statements → Open the FLGT valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $324M | $323M | $283M | $289M | $619M | $993M | $422M | $33M | $21M | $19M | $18M | $10M | $1M |
| Gross Profit | $115M | $131M | $107M | $104M | $367M | $777M | $332M | $18M | $11M | $10M | $12M | $5M | $0M |
| Gross Margin % | 35.6% | 40.6% | 37.8% | 36.1% | 59.3% | 78.3% | 78.7% | 56.6% | 49.9% | 54.4% | 63.2% | 47.1% | 26.8% |
| Operating Income (EBIT) | ($120M) | ($91M) | ($74M) | ($196M) | $179M | $104M | $290M | $0M | ($5M) | ($3M) | $1M | ($5M) | ($1M) |
| Operating Margin % | -37.1% | -28.2% | -26.1% | -67.6% | 28.8% | 10.5% | 68.8% | -1.3% | -23.7% | -18.1% | 5.0% | -52.3% | -77.5% |
| Net Income | ($84M) | ($61M) | ($43M) | ($168M) | $143M | $104M | $214M | $0M | ($4M) | ($3M) | ($5M) | ($8M) | ($4M) |
| Net Margin % | -26.1% | -18.8% | -15.1% | -58.0% | 23.2% | 10.5% | 50.8% | 1.1% | -21.0% | -14.2% | -29.5% | -86.8% | -335.1% |
| EBITDA | ($65M) | ($46M) | ($27M) | ($147M) | $218M | $106M | $293M | $2M | ($3M) | ($2M) | $2M | ($4M) | ($1M) |
| Earnings Per Share (EPS) | $-2.83 | $-1.97 | $-1.41 | $-5.63 | $4.63 | $3.37 | $8.91 | $0.02 | $-0.25 | $-0.15 | $-0.30 | $-0.65 | $-0.24 |
| Shares Outstanding (M) | 28M | 31M | 30M | 30M | 31M | 31M | 24M | 19M | 18M | 18M | 18M | 13M | 18M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $85M | $71M | $83M | $84M | $82M | $73M | $76M | $72M |
| Gross Profit | $26M | $21M | $33M | $36M | $34M | $28M | $32M | $27M |
| Gross Margin % | 30.1% | 30.2% | 39.1% | 42.2% | 42.1% | 38.6% | 41.8% | 37.3% |
| Operating Income (EBIT) | ($34M) | ($35M) | ($36M) | ($15M) | ($20M) | ($20M) | ($16M) | ($17M) |
| Operating Margin % | -39.7% | -48.7% | -43.5% | -18.3% | -24.1% | -27.0% | -21.2% | -23.8% |
| Net Income | ($30M) | ($25M) | ($23M) | ($7M) | ($19M) | ($12M) | ($6M) | ($15M) |
| Net Margin % | -34.6% | -34.9% | -28.1% | -7.9% | -23.2% | -15.7% | -7.7% | -20.4% |
| EBITDA | ($22M) | ($20M) | ($23M) | $0M | ($15M) | ($6M) | ($2M) | ($13M) |
| Earnings Per Share (EPS) | $-1.05 | $-0.80 | $-0.76 | $-0.21 | $-0.61 | $-0.37 | $-0.19 | $-0.48 |
| Shares Outstanding (M) | 28M | 31M | 31M | 31M | 31M | 31M | 31M | 30M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($84M) | ($102M) | $21M | $27M | $254M | $539M | $141M | $6M | ($1M) | $1M | $4M | ($1M) | ($4M) |
| Capital Expenditures (CapEx) | $20M | $23M | $40M | $22M | $19M | $24M | $37M | $1M | $3M | $5M | $4M | $2M | $1M |
| Free Cash Flow (FCF) | ($104M) | ($124M) | ($19M) | $5M | $235M | $515M | $104M | $4M | ($4M) | ($4M) | $1M | ($3M) | ($5M) |
| FCF Margin % | -32.0% | -38.5% | -6.8% | 1.7% | 37.9% | 51.9% | 24.7% | 13.3% | -16.4% | -21.5% | 3.4% | -32.0% | -401.2% |
| Dividends Paid | — | — | — | — | — | $4M | $15M | — | — | $0M | $5M | $5M | $5M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($24M) | $7M | ($78M) | $11M | ($30M) | ($4M) | $25M | ($16M) |
| Capital Expenditures (CapEx) | $4M | $5M | $5M | $6M | $7M | $5M | $4M | $20M |
| Free Cash Flow (FCF) | ($28M) | $2M | ($83M) | $5M | ($37M) | ($9M) | $21M | ($35M) |
| FCF Margin % | -32.3% | 2.7% | -99.7% | 6.0% | -45.2% | -12.4% | 27.9% | -48.9% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B | $1.2B | $1.2B | $1.2B | $1.4B | $1.3B | $700M | $89M | $55M | $57M | $58M | $6M | $2M |
| Cash & Cash Equivalents | $26M | $50M | $55M | $97M | $80M | $165M | $87M | $12M | $7M | $6M | $8M | $0M | $0M |
| Total Liabilities | $93M | $107M | $91M | $102M | $116M | $113M | $131M | $6M | $3M | $3M | $4M | $1M | $0M |
| Total Debt (Short + Long-Term) | $4M | $4M | $4M | $8M | $30M | $21M | $15M | $0M | $0M | $0M | $0M | $0M | $0M |
| Total Shareholders' Equity | $1.0B | $1.1B | $1.1B | $1.1B | $1.3B | $1.2B | $569M | $83M | $52M | $54M | $54M | $5M | $2M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FLGT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms